NCT07367061 is a NA clinical trial of product: Innea Aqua vaginal use in Vulvo Vaginal Atrophy, sponsored by Innate srl.

Who is sponsoring NCT07367061?

NCT07367061 is sponsored by Innate srl.

What drugs are being tested in NCT07367061?

Interventions in NCT07367061: product: Innea Aqua vaginal use, arm 2: standard of care.

What condition does NCT07367061 study?

NCT07367061 studies Vulvo Vaginal Atrophy.

Is NCT07367061 still recruiting?

NCT07367061 is currently active, enrolled. Last updated 9 February 2026.

Last reviewed 2026-02-09 · How we verify

NCT07367061

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Investigation to Assess Safety and Efficacy of INNEA AQUA in Adult Women With Vulvo-Vaginal Atrophy (VVA)

Active, enrolled NA Last updated 9 February 2026

What this trial tests

NA trial testing product: Innea Aqua vaginal use in Vulvo Vaginal Atrophy in 62 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

25 September 2025

Primary endpoint
30 May 2026

30 June 2026

Quick facts

Lead sponsor	Innate srl
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	62
Start date	25 September 2025
Primary completion	30 May 2026
Estimated completion	30 June 2026
Sites	3 locations across Romania

Drugs / interventions tested

product: Innea Aqua vaginal use
arm 2: standard of care

Conditions studied

Vulvo Vaginal Atrophy — all drugs for Vulvo Vaginal Atrophy →

Sponsor

Innate srl

Who can join

Adults 18 to 75, female only, with Vulvo Vaginal Atrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clinical investigation to assess safety and efficacy of INNEA AQUA in adult women with Vulvo-Vaginal Atrophy (VVA). To assess the Safety and efficacy of INNEA AQUA

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Innate srl trials

Trials by the same sponsor.

NCT07331181 — Evaluation of Performance and Safety of INNEA and INNEA AQUA for the Treatment of Cheek and décolletage Wrinkles · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07367061 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Innate srl
Last refreshed: 9 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07367061.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing